Insomnia, Current, and, Future, Players: Ken Research
Insomnia - Current and Future Players

Insomnia - Current and Future Players

  • Products Id :- GDHC1062FPR
  • |
  • Pages: 114
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Insomnia - Current and Future Players


GlobalData has released its pharma report, ''Insomnia - Current and Future Players''. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Insomnia Market. The report identifies and analyses the key companies shaping and driving the global Insomnia market. The report provides insight into the competitive Insomnia landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.


Investigation of current and future market competition for Insomnia

Competitor assessment

Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

Strategic assessment of Insomnia sector through market impact analysis, future market scenario and company analysis

Reasons to buy

Gain a high level view of the trends shaping and driving Insomnia market

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

Create an effective counter-strategy to gain a competitive advantage against those currently in the market

What's the next big thing in the global Insomnia market landscape? Identify, understand and capitalize

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Catalyst 6

2.2 Related Reports 6

3 Market Outlook 7

3.1 Global Markets 7

3.1.1 Forecast 7

3.1.2 Drivers and Barriers - Global Issues 11

4 Current and Future Players 14

4.1 Overview 14

4.2 Trends in Corporate Strategy 18

4.3 Company Profiles 20

4.3.1 Sanofi 20

4.3.2 Sunovion/Dainippon Sumitomo 23

4.3.3 Pfizer 25

4.3.4 Takeda 29

4.3.5 Merck & Co. 32

4.3.6 Meda 36

4.3.7 Eisai 39

4.3.8 Purdue 41

4.3.9 Neurim 44

4.3.10 Pernix Therapeutics 48

5 Appendix 51

5.1 Bibliography 51

5.2 Abbreviations 85

5.3 Methodology 89

5.4 Forecasting Methodology 89

5.4.1 Diagnosed Insomnia Patients 89

5.4.2 Percent Drug-Treated Patients 90

5.4.3 Drugs Included in Each Therapeutic Class 90

5.4.4 Launch and Patent Expiry Dates 91

5.4.5 General Pricing Assumptions 92

5.4.6 Individual Drug Assumptions 93

5.4.7 Generic Erosion 106

5.4.8 Pricing of Pipeline Agents 107

5.5 Primary Research - KOLs Interviewed for this Report 108

5.6 Primary Research - Prescriber Survey 110

5.7 About the Authors 111

5.7.1 Analyst 111

5.7.2 Therapy Area Director 111

5.7.3 Epidemiologist 112

5.7.4 Global Head of Healthcare 112

5.8 About GlobalData 113

5.9 Disclaimer 113

1.2 List of Figures

Figure 1: Global Sales for Insomnia by Region, 2013-2023 10

Figure 2: Global Sales of Products for Insomnia by Company, 2013-2023 17

Figure 3: Company Portfolio Gap Analysis in Insomnia, 2013-2023 18

Figure 4: Sanofi SWOT Analysis in Insomnia, 2013-2023 22

Figure 5: Sunovion/Dainippon Sumitomo SWOT Analysis in Insomnia, 2013-2023 25

Figure 6: Pfizer SWOT Analysis in Insomnia, 2013-2023 29

Figure 7: Takeda SWOT Analysis in Insomnia, 2013-2023 31

Figure 8: Merck SWOT Analysis in Insomnia, 2013-2023 36

Figure 9: Meda SWOT Analysis in Insomnia, 2013-2023 39

Figure 10: Eisai SWOT Analysis in Insomnia, 2013-2023 41

Figure 11: Purdue SWOT Analysis in Insomnia, 2013-2023 44

Figure 12: Neurim SWOT Analysis in Insomnia, 2013-2023 47

Figure 13: Pernix Therapeutics SWOT Analysis in Insomnia, 2013-2023 50

1.1 List of Tables

Table 1: Global Sales Forecast (USDm) for Insomnia, 2013-2023 9

Table 2: Insomnia Market - Drivers and Barriers, 2013-2023 11

Table 3: Key Companies in the Insomnia Market in the 7MM, 2013 16

Table 4: Sanofi's Insomnia Portfolio Assessment, 2015 22

Table 5: Sunovion/Dainippon Sumitomo's Insomnia Portfolio Assessment, 2015 24

Table 6: Pfizer's Insomnia Portfolio Assessment, 2015 28

Table 7: Takeda's Insomnia Portfolio Assessment, 2015 31

Table 8: Merck's Insomnia Portfolio Assessment, 2015 35

Table 9: Meda's Insomnia Portfolio Assessment, 2015 38

Table 10: Eisai's Insomnia Portfolio Assessment, 2015 40

Table 11: Purdue's Insomnia Portfolio Assessment, 2015 43

Table 12: Neurim's Insomnia Portfolio Assessment, 2015 47

Table 13: Pernix Therapeutics' Insomnia Portfolio Assessment, 2015 49

Table 14: Key Launch Dates 91

Table 15: Key Patent Expiries 91

Table 16: High-Prescribing Physicians (Non-KOLs) Surveyed, By Country 110

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]


Sunovion/Dainippon Sumitomo



Merck & Co.





Pernix Therapeutics

select a license

Single User License
USD 2995 INR 202013
Site License
USD 5990 INR 404026
Corporate User License
USD 8985 INR 606038



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]